These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2066688)

  • 1. The ubiquitous polycystic ovary.
    Franks S
    J Endocrinol; 1991 Jun; 129(3):317-9. PubMed ID: 2066688
    [No Abstract]   [Full Text] [Related]  

  • 2. The pathophysiology of polycystic ovary syndrome.
    Tsilchorozidou T; Overton C; Conway GS
    Clin Endocrinol (Oxf); 2004 Jan; 60(1):1-17. PubMed ID: 14678281
    [No Abstract]   [Full Text] [Related]  

  • 3. Ovarian influence on adrenal androgen secretion in polycystic ovary syndrome.
    Fruzzetti F; De Lorenzo D; Ricci C; Teti G
    Fertil Steril; 1995 Apr; 63(4):734-41. PubMed ID: 7890056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contributions of oestrogen and growth factors to increased adrenal androgen secretion in polycystic ovary syndrome.
    Carmina E; Gonzalez F; Vidali A; Stanczyk FZ; Ferin M; Lobo RA
    Hum Reprod; 1999 Feb; 14(2):307-11. PubMed ID: 10099969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the polycystic ovary syndrome.
    Givens JR; Kurtz BR
    Prog Clin Biol Res; 1986; 225():355-76. PubMed ID: 3097672
    [No Abstract]   [Full Text] [Related]  

  • 6. The androgenic polycystic ovary.
    Greenblatt RB; Mahesh VB
    Am J Obstet Gynecol; 1976 Jul; 125(5):712-26. PubMed ID: 180807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgens in polycystic ovary syndrome: the role of exercise and diet.
    Giallauria F; Palomba S; Vigorito C; Tafuri MG; Colao A; Lombardi G; Orio F
    Semin Reprod Med; 2009 Jul; 27(4):306-15. PubMed ID: 19530064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polycystic ovary syndrome: from physiopathology to therapy].
    Pugeat M
    Ann Endocrinol (Paris); 1998 Nov; 59(4):305-9. PubMed ID: 9864551
    [No Abstract]   [Full Text] [Related]  

  • 9. [Polycystic ovary syndrome].
    Campodónico I; Cheviakoff S; Devoto L; Glavic A; Porcile A; Reid I
    Rev Chil Obstet Ginecol; 1983; 48(1):16-26. PubMed ID: 6681188
    [No Abstract]   [Full Text] [Related]  

  • 10. Polycystic ovary syndrome: obesity, insulin resistance, hyperandrogenism.
    Lo Dico G; Alongi G; Savatteri L; Rini GB; Mascellino MR; Di Fede G; Rizzo G
    Acta Eur Fertil; 1989; 20(5):309-13. PubMed ID: 2700062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-sensitizing agents and their effect on adrenal androgens.
    Unlühizarci K; Keleştimur F; Bayram F
    Fertil Steril; 2000 Nov; 74(5):1058-9. PubMed ID: 11185467
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduction of endogenous, ovarian and adrenal androgens with ketoconazole does not alter insulin response in the polycystic ovary syndrome.
    Vidal-Puig A; Muñoz-Torres M; Garcia-Calvente C; Jodar-Gimeno E; Lardelli P; Ruiz-Requena ME; Escobar-Jiménez F
    J Endocrinol Invest; 1994 Sep; 17(8):647-52. PubMed ID: 7868804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Variability of the adrenal involvement in the polycystic ovary syndrome].
    Boccuzzi G
    Minerva Endocrinol; 1987; 12(3):213-6. PubMed ID: 2821374
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathogenesis of polycystic ovarian disease.
    James R; Givens MD
    Acta Eur Fertil; 1979 Sep; 10(3):89-103. PubMed ID: 121017
    [No Abstract]   [Full Text] [Related]  

  • 15. Polycystic ovary syndrome.
    Cheung AP; Chang RJ
    Clin Obstet Gynecol; 1990 Sep; 33(3):655-67. PubMed ID: 2225592
    [No Abstract]   [Full Text] [Related]  

  • 16. Steroidogenic alterations and adrenal androgen excess in PCOS.
    Doi SA; Al-Zaid M; Towers PA; Scott CJ; Al-Shoumer KA
    Steroids; 2006 Sep; 71(9):751-9. PubMed ID: 16781743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome.
    Gonzalez F; Hatala DA; Speroff L
    Am J Obstet Gynecol; 1991 Sep; 165(3):535-45. PubMed ID: 1832519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian, adrenal, and peripheral testosterone levels in the polycystic ovary syndrome.
    Stahl NL; Teeslink CR; Greenblatt RB
    Am J Obstet Gynecol; 1973 Sep; 117(2):194-200. PubMed ID: 4728868
    [No Abstract]   [Full Text] [Related]  

  • 19. Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome.
    Puurunen J; Piltonen T; Jaakkola P; Ruokonen A; Morin-Papunen L; Tapanainen JS
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1973-8. PubMed ID: 19318449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of a CYP17 polymorphism in the regulation of circulating dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome.
    Kahsar-Miller M; Boots LR; Bartolucci A; Azziz R
    Fertil Steril; 2004 Oct; 82(4):973-5. PubMed ID: 15482786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.